Nature's Sunshine Q1 net sales $122.9M (+9% YoY), EPS $0.29 (+16%), adj. EBITDA +33%

Net sales were up 9% to $122.9 million compared to $113.2 million (up 7% in constant currency).

The Company’s shareholders voted upon and ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026. The following table sets forth the vote of the shareholders at the Annual Meeting with respect to the ratification of Deloitte & Touche LLP: For Against Abstain 14,619,306 566,274 32,729 There were no broker non-votes in the ratification of appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026.

The Company’s shareholders voted upon and ratified the 2026 Stock Incentive Plan. The following table sets forth the votes of the shareholders at the Annual Meeting with respect to the 2026 Stock Incentive Plan. For Against Abstain Broker Non-Votes 6,357,245 5,723,107 1,850,962 1,286,995

The Company’s shareholders, on an advisory basis, voted to approve an advisory resolution to approve the compensation of the Company’s named executive officers as follows: For Against Abstain Broker Non-Votes 11,288,205 779,056 1,864,053 1,286,995

The Company held its Annual Meeting of Shareholders on May 6, 2026 (the "Annual Meeting"). The proposals voted upon at the Annual Meeting and the final results of the shareholder vote on each proposal are set forth below.